Showing results (1251-1260 of 1,407) with videos related to

Sort By:
Pageof 141
Pharmacology Research & Perspectives|July 29, 2022
The effect of substance P and its common in vivo-formed metabolites on MRGPRX2 and human mast cell activationLin Hsin, Nithya A Fernandopulle, Jie Ding, et al.
Pharmacology Research & Perspectives|August 5, 2014
Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1αSanjoy Roychowdhury, Dian J Chiang, Megan R McMullen, et al.
Pharmacology Research & Perspectives|March 30, 2016
Claudin-4 binder C-CPE 194 enhances effects of anticancer agents on pancreatic cancer cell lines via a MAPK pathwayTsuyoshi Kono, Masuo Kondoh, Daisuke Kyuno, et al.
Pharmacology Research & Perspectives|March 30, 2016
Bioequivalence of saxagliptin/dapagliflozin fixed-dose combination tablets compared with coadministration of the individual tablets to healthy subjectsBlisse Vakkalagadda, Marion L Vetter, Jignasa Rana, et al.
Pharmacology Research & Perspectives|April 13, 2016
Pharmacological evaluation of a series of smoothened antagonists in signaling pathways and after topical application in a depilated mouse modelEmilie Lauressergues, Peter Heusler, Fabrice Lestienne, et al.
Pharmacology Research & Perspectives|April 13, 2016
Structure-activity relationship study of angiotensin II analogs in terms of β-arrestin-dependent signaling to aldosterone productionThairy Reyes Valero, Emmanuel Sturchler, Malika Jafferjee, et al.
Pharmacology Research & Perspectives|April 13, 2016
Nonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma-derived human FXIII concentrate in animalsAndrea Beyerle, Cristina Solomon, Gerhard Dickneite, et al.
Pharmacology Research & Perspectives|April 13, 2016
Downregulation of the Ca(2+)-activated K(+) channel KC a3.1 by histone deacetylase inhibition in human breast cancer cellsSusumu Ohya, Saki Kanatsuka, Noriyuki Hatano, et al.
Pharmacology Research & Perspectives|August 15, 2017
The reversible P2Y12 antagonist ACT-246475 causes significantly less blood loss than ticagrelor at equivalent antithrombotic efficacy in ratMarkus Rey, Markus Kramberg, Patrick Hess, et al.
Pharmacology Research & Perspectives|August 15, 2017
A novel free fatty acid receptor 1 (GPR40/FFAR1) agonist, MR1704, enhances glucose-dependent insulin secretion and improves glucose homeostasis in ratsNaoto Tsuda, Atsuko Kawaji, Toshihiro Sato, et al.
Pageof 141